The overlap volume histogram (OVH) is an anatomical metric commonly used to quantify the geometric relationship between an organ at risk (OAR) and target volume when predicting expected dose-volumes in knowledge-based planning (KBP). This work investigated the influence of additional variables contributing to variations in the assumed linear DVH-OVH correlation for the bladder and rectum in VMAT plans of prostate patients, with the goal of increasing prediction accuracy and achievability of knowledge-based planning methods. VMAT plans were retrospectively generated for 124 prostate patients using multi-criteria optimization. DVHs quantified patient dosimetric data while OVHs quantified patient anatomical information. The DVH-OVH correlations were calculated for fractional bladder and rectum volumes of 30, 50, 65, and 80%. Correlations between potential influencing factors and dose were quantified using the Pearson product-moment correlation coefficient (R). Factors analyzed included the derivative of the OVH, prescribed dose, PTV volume, bladder volume, rectum volume, and in-field OAR volume. Out of the selected factors, only the in-field bladder volume (mean R  =  0.86) showed a strong correlation with bladder doses. Similarly, only the in-field rectal volume (mean R  =  0.76) showed a strong correlation with rectal doses. Therefore, an OVH formalism accounting for in-field OAR volumes was developed to determine the extent to which it improved the DVH-OVH correlation. Including the in-field factor improved the DVH-OVH correlation, with the mean R values over the fractional volumes studied improving from  -0.79 to  -0.85 and  -0.82 to  -0.86 for the bladder and rectum, respectively. A re-planning study was performed on 31 randomly selected database patients to verify the increased accuracy of KBP dose predictions by accounting for bladder and rectum volume within treatment fields. The in-field OVH led to significantly more precise and fewer unachievable KBP predictions, especially for lower bladder and rectum dose-volumes.

Collimated supersonic flows in laboratory experiments behave in a similar manner to astrophysical jets provided that radiation, viscosity, and thermal conductivity are unimportant in the laboratory jets, and that the experimental and astrophysical jets share similar dimensionless parameters such as the Mach number and the ratio of the density between the jet and the ambient medium. When these conditions apply, laboratory jets provide a means to study their astrophysical counterparts for a variety of initial conditions, arbitrary viewing angles, and different times, attributes especially helpful for interpreting astronomical images where the viewing angle and initial conditions are fixed and the time domain is limited. Experiments are also a powerful way to test numerical fluid codes in a parameter range where the codes must perform well. In this paper we combine images from a series of laboratory experiments of deflected supersonic jets with numerical simulations and new spectral observations of an astrophysical example, the young stellar jet HH 110. The experiments provide key insights into how deflected jets evolve in 3-D, particularly within working surfaces where multiple subsonic shells and filaments form, and along the interface where shocked jet material penetrates into and destroys the obstacle along its path. The experiments also underscore the importance of the viewing angle in determining what an observer will see. The simulations match the experiments so well that we can use the simulated velocity maps to compare the dynamics in the experiment with -2those implied by the astronomical spectra. The experiments support a model where the observed shock structures in HH 110 form as a result of a pulsed driving source rather than from weak shocks that may arise in the supersonic shear layer between the Mach disk and bow shock of the jet's working surface.

Purpose Bolus electron conformal therapy (BECT) is a clinically useful, well‐documented, and available technology. The addition of intensity modulation (IM) to BECT reduces volumes of high dose and dose spread in the planning target volume (PTV). This paper demonstrates new techniques for a process that should be suitable for planning and delivering IM‐BECT using passive radiotherapy intensity modulation for electrons (PRIME) devices. Methods The IM‐BECT planning and delivery process is an addition to the BECT process that includes intensity modulator design, fabrication, and quality assurance. The intensity modulator (PRIME device) is a hexagonal matrix of small island blocks (tungsten pins of varying diameter) placed inside the patient beam‐defining collimator (cutout). Its design process determines a desirable intensity‐modulated electron beam during the planning process, then determines the island block configuration to deliver that intensity distribution (segmentation). The intensity modulator is fabricated and quality assurance performed at the factory (.decimal, LLC, Sanford, FL). Clinical quality assurance consists of measuring a fluence distribution in a plane perpendicular to the beam in a water or water‐equivalent phantom. This IM‐BECT process is described and demonstrated for two sites, postmastectomy chest wall and temple. Dose plans, intensity distributions, fabricated intensity modulators, and quality assurance results are presented. Results IM‐BECT plans showed improved D90‐10 over BECT plans, 6.4% versus 7.3% and 8.4% versus 11.0% for the postmastectomy chest wall and temple, respectively. Their intensity modulators utilized 61 (single diameter) and 246 (five diameters) tungsten pins, respectively. Dose comparisons for clinical quality assurance showed that for doses greater than 10%, measured agreed with calculated dose within 3% or 0.3 cm distance‐to‐agreement (DTA) for 99.9% and 100% of points, respectively. Conclusion These results demonstrated the feasibility of translating IM‐BECT to the clinic using the techniques presented for treatment planning, intensity modulator design and fabrication, and quality assurance processes.